(Q37370043)

20 August 2017

1 reference

title

Metabolic syndrome and cardiometabolic risk: an update (English)

1 reference

20 August 2017

1 reference

6

Giuseppe Mancia

1 reference

20 August 2017

1

Guido Grassi

1 reference

20 August 2017

Gino Seravalle

2

1 reference

20 August 2017

Fosca Quarti-Trevano

series ordinal

3

1 reference

20 August 2017

Raffaella Dell'Oro

series ordinal

4

1 reference

20 August 2017

Michele Bombelli

series ordinal

5

1 reference

20 August 2017

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

18

1 reference

20 August 2017

1-2

1 reference

20 August 2017

7-16

1 reference

A comparison of the prevalence of the metabolic syndrome using two proposed definitions

20 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

2007 ESH‐ESC Guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The metabolic syndrome: one step forward, two steps back

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Metabolic syndrome, or What you will: definitions and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Hypertension and the metabolic syndrome: closely related central origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Metabolic syndrome and echocardiographic left ventricular mass in blacks - the atherosclerosis risk in communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Left ventricular contractility and insulin resistance in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Left atrial size and the risk of stroke and death. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Atrial fibrillation in hypertension: predictors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

PPARs and the kidney in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The sympathetic nervous system and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The sympathetic nervous system and obstructive sleep apnea: implications for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

The metabolic syndrome in hypertension: European society of hypertension position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

New-onset diabetes and antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037050802677695

10.1080/08037050802677695

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference